These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17076529)

  • 1. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
    Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P
    Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
    Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
    Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
    Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
    J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.
    Kashyap S; Sethi S; Meel R; Pushker N; Sen S; Bajaj MS; Chandra M; Ghose S
    Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
    Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
    Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcification in retinoblastoma: histopathologic findings and statistical analysis of 302 cases.
    Levy J; Frenkel S; Baras M; Neufeld M; Pe'er J
    Br J Ophthalmol; 2011 Aug; 95(8):1145-50. PubMed ID: 21273212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical predictors of high risk histopathology in retinoblastoma.
    Kashyap S; Meel R; Pushker N; Sen S; Bakhshi S; Sreenivas V; Sethi S; Chawla B; Ghose S
    Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
    Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
    J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
    Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
    Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.
    Marback EF; Arias VE; Paranhos A; Soares FA; Murphree AL; Erwenne CM
    Br J Ophthalmol; 2003 Oct; 87(10):1224-8. PubMed ID: 14507753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Imaging Can Reliably Differentiate Optic Nerve Inflammation from Tumor Invasion in Retinoblastoma with Orbital Cellulitis.
    Jansen RW; van der Heide S; Cardoen L; Sirin S; de Bloeme CM; Galluzzi P; Göricke S; Brisse HJ; Maeder P; Sen S; Biewald E; Castelijns JA; Moll AC; van der Valk P; de Jong MC; de Graaf P;
    Ophthalmology; 2022 Nov; 129(11):1275-1286. PubMed ID: 35752210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.
    Yousef YA; Hajja Y; Nawaiseh I; Mehyar M; Sultan I; Deebajah R; Rawashdeh K; Khurma S; Jaradat I; Al-Hussaini M
    Turk Patoloji Derg; 2014; 30(3):171-7. PubMed ID: 24913302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
    Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
    Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma with low risk for extraocular relapse.
    Chantada GL; de Dávila MT; Fandiño A; Manzitti J; Raslawski E; Casak S; Schvartzman E
    Ophthalmic Genet; 1999 Sep; 20(3):133-40. PubMed ID: 10520234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
    Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
    Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic retinoblastoma clinical features, treatment, and prognosis.
    Gündüz K; Müftüoglu O; Günalp I; Unal E; Taçyildiz N
    Ophthalmology; 2006 Sep; 113(9):1558-66. PubMed ID: 16828510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
    Deng X; Cheng Y; Zhu XM; Linghu DD; Zhao MW; Liang JH
    Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):681-687. PubMed ID: 32907301
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
    Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
    Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current therapeutic management in retinoblastoma with invasion of the optic nerve--a case report].
    Gavriş M; Neamţu S; Gavriş S; Ghiţuică A
    Oftalmologia; 1999; 46(1):69-71. PubMed ID: 10641091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.